How should normal skin findings be documented in the physical examination note?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Documentation of Normal Skin Findings in Physical Examination Notes

When documenting normal skin findings, report that the skin examination was performed and describe it as "normal" or "negative," without the need for extensive descriptive detail when no abnormalities are present. 1

Standard Documentation Framework

For Normal Findings

  • State explicitly that a skin examination was performed and document the result as "normal," "unremarkable," or "no abnormalities detected" 1

  • The physical examination note should confirm that the skin was visually inspected, but extensive description of normal characteristics is unnecessary when findings are benign 1

  • For comprehensive examinations (such as melanoma surveillance or HIV care), document that a "complete" or "full-body" skin examination was performed, including all skin surfaces 1, 2

Essential Elements to Include

  • Document the extent of examination: Specify whether you performed a focused examination of one area versus a complete skin examination of all body surfaces 1, 2

  • For complete skin examinations, note that you examined:

    • All skin surfaces including scalp 2
    • Special attention areas when relevant (e.g., sun-exposed areas, intertriginous zones) 1
    • Mucous membranes when indicated by clinical context 1
  • Use standardized terminology such as "skin: normal" or "skin: no rashes, lesions, or masses noted" rather than creating varied descriptive phrases 1

When to Expand Documentation

Document Specific Normal Findings When Clinically Relevant

  • In high-risk populations (e.g., patients on immunotherapy, HIV-infected patients, melanoma surveillance), explicitly state the absence of specific concerning findings 1, 2:

    • "No suspicious pigmented lesions"
    • "No evidence of seborrheic dermatitis, Kaposi sarcoma, or fungal infections" 1
    • "No rash, blistering, or erythema" 1
  • For pediatric examinations, document normal skin color, perfusion, and absence of rashes or lesions as part of the comprehensive assessment 3

  • When examining patients with cancer or on systemic therapies, note the absence of treatment-related skin changes 1

Common Pitfalls to Avoid

  • Do not omit documentation of the skin examination entirely—this creates medicolegal risk and suggests an incomplete physical examination 1, 4

  • Avoid overly detailed descriptions of normal anatomy (e.g., "skin is smooth, soft, warm, dry, intact with normal turgor")—this adds documentation burden without clinical value 1

  • Do not use inconsistent terminology across examinations—develop a standardized format for your practice 1

  • For complete skin examinations, do not document only the presenting area—explicitly state that distant sites were examined, as this has been shown to detect occult malignancies in 0.6-3.3% of patients 4

Practical Documentation Examples

Brief Normal Documentation

  • "Skin: Normal examination, no lesions"
  • "Skin: Unremarkable, no rashes or masses"
  • "Complete skin examination performed: normal" 1

Expanded Normal Documentation (High-Risk Contexts)

  • "Complete skin examination including scalp performed. No suspicious pigmented lesions, no evidence of secondary melanoma" 2
  • "Skin examination: No rash, no evidence of seborrheic dermatitis, Kaposi sarcoma, or fungal infection" 1
  • "Full body skin examination: No bullae, erosions, or erythema. No evidence of immune-related adverse events" 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Post‑Melanoma Surveillance for Women After Complete Excision of Primary Cutaneous Melanoma with Clear Margins

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Comprehensive Physical Examination for 15-Month-Old Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

How do I perform a methodical skin check?
What is the recommended history, examination, investigations and initial management for a patient with unexplained generalized pruritus?
What are the key aspects to consider in a dermatological consultation?
How should I document a comprehensive skin examination, including normal findings and any lesions, using standardized terminology?
What is the appropriate work‑up for a patient presenting with pruritus?
What is the appropriate acute management for a 63‑year‑old postmenopausal obese woman on oral hormone replacement therapy (Femoston (estradiol/dydrogesterone)) presenting with acute left upper‑extremity weakness suggestive of a right middle cerebral artery ischemic stroke?
What baseline laboratory tests should be ordered for a healthy lactating mother without specific complaints to screen for anemia, iron status, organ function, thyroid function, vitamin D, calcium, phosphorus, folate, vitamin B12, glucose or hemoglobin A1c (if diabetic risk), infectious diseases (HIV, hepatitis B and C, syphilis, HTLV‑1/2) and medication levels if she is taking drugs that pass into breast milk?
What could cause the acute decline in renal function in an 86‑year‑old woman with stage 0 chronic lymphocytic leukaemia, hypogammaglobulinaemia, hypertension, hyperlipidaemia, recurrent bacterial sinus infections, mild dementia and arthritis presenting with nausea and abdominal pain?
What is the recommended treatment approach for a patient with ulcerative colitis involving the entire colon (pancolitis)?
What does a wide pulse pressure suggest?
Is there a standard multidisciplinary protocol for initiating puberty suppression with GnRH (gonadotropin‑releasing hormone) agonists in adolescents with gender dysphoria at early puberty (Tanner stage 2), including required assessments and monitoring?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.